Oxyntomodulin

Also known as: OXM

Dual GLP-1/Glucagon agonist

What is Oxyntomodulin?

Oxyntomodulin is a peptide hormone derived from proglucagon, primarily produced in the intestines. It is classified as a dual GLP-1/glucagon agonist, making it significant in the field of metabolic peptides. Oxyntomodulin plays a crucial role in regulating appetite and energy expenditure, positioning it as a potential target for weight management and metabolic health.

How It Works

Oxyntomodulin functions by activating both GLP-1 (Glucagon-Like Peptide-1) and glucagon receptors, which leads to a complex interplay of metabolic effects.

Mechanism of Action

Upon release, Oxyntomodulin enhances insulin secretion while simultaneously inhibiting glucagon release, contributing to improved glucose homeostasis. Additionally, it promotes satiety by acting on the central nervous system, thereby reducing food intake and increasing energy expenditure.

Research Uses

  • Appetite Regulation

    Studies indicate that Oxyntomodulin may help in reducing food intake, making it a focus for obesity research.
  • Weight Management

    Research explores its potential in aiding weight loss by enhancing metabolic rates and promoting fat oxidation.
  • Diabetes Management

    Investigations are underway to assess its role in improving glycemic control in type 2 diabetes patients.
  • Energy Expenditure

    Oxyntomodulin's effects on energy balance are being studied for implications in metabolic disorders.

Effects

  • Reduced Appetite

    Users and studies report a significant decrease in hunger levels following Oxyntomodulin administration.
  • Increased Satiety

    Observations suggest enhanced feelings of fullness, which may contribute to lower caloric intake.
  • Improved Glycemic Control

    Research indicates potential benefits in blood sugar regulation, particularly in diabetic models.
  • Enhanced Fat Oxidation

    Some studies show an increase in fat metabolism, which could aid in weight loss efforts.

Summary

Oxyntomodulin is a promising peptide with dual action on GLP-1 and glucagon receptors, making it relevant in the study of fat loss and metabolic health. Its effects on appetite regulation and energy expenditure highlight its potential applications in obesity and diabetes research.

Last updated: Feb 25, 2026